Reuters logo
BRIEF-Galmed Pharma says completes patient recruitment for ARREST phase IIb NASH study
January 9, 2017 / 1:28 PM / 10 months ago

BRIEF-Galmed Pharma says completes patient recruitment for ARREST phase IIb NASH study

Jan 9 (Reuters) - Galmed Pharmaceuticals Ltd

* Galmed pharmaceuticals ltd- completed recruitment for its phase iib arrest study; results from study are anticipated to be announced in q2 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below